ATIP RSI Chart
Last 7 days
-5.6%
Last 30 days
-33.4%
Last 90 days
-37.2%
Trailing 12 Months
-69.2%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 648.8M | 657.8M | 678.5M | 699.0M |
2022 | 632.6M | 631.9M | 629.7M | 635.7M |
2021 | 570.5M | 626.8M | 637.1M | 627.9M |
2020 | 0 | 721.1M | 656.7M | 592.3M |
2019 | 0 | 0 | 0 | 785.5M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 22, 2024 | kantz erik | sold (taxes) | -8,736 | 6.08 | -1,437 | chief legal officer |
Mar 22, 2024 | cox christopher l | sold (taxes) | -34,990 | 6.08 | -5,755 | chief operating officer |
Mar 22, 2024 | cox christopher l | sold (taxes) | -35,112 | 6.08 | -5,775 | chief operating officer |
Mar 22, 2024 | gregerson scott | sold (taxes) | -20,617 | 6.08 | -3,391 | chief growth officer |
Mar 22, 2024 | oakes augustus | sold (taxes) | -8,736 | 6.08 | -1,437 | chief information officer |
Mar 22, 2024 | jordan joseph francis | sold (taxes) | -42,292 | 6.08 | -6,956 | chief financial officer |
Mar 22, 2024 | rhodes brent michael | sold (taxes) | -5,928 | 6.08 | -975 | chief accounting officer |
Mar 22, 2024 | vitti sharon | sold (taxes) | -92,531 | 6.08 | -15,219 | chief executive officer |
Mar 22, 2024 | tansey eimile | sold (taxes) | -17,467 | 6.08 | -2,873 | chief people officer |
Mar 16, 2024 | kantz erik | sold (taxes) | -76.92 | 6.41 | -12.00 | chief legal officer |
Which funds bought or sold ATIP recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Apr 23, 2024 | AMALGAMATED BANK | sold off | -100 | - | - | -% |
Apr 19, 2024 | LAKE STREET PRIVATE WEALTH, LLC | unchanged | - | -10.00 | 6.00 | -% |
Apr 19, 2024 | Cutler Group LLC / CA | sold off | -100 | - | - | -% |
Mar 11, 2024 | VANGUARD GROUP INC | unchanged | - | -181,053 | 408,696 | -% |
Feb 28, 2024 | AMERICAN INTERNATIONAL GROUP, INC. | unchanged | - | -6.00 | 12.00 | -% |
Feb 14, 2024 | Fortress Investment Group LLC | unchanged | - | -871,760 | 1,967,870 | 0.23% |
Feb 14, 2024 | Advent International, L.P. | unchanged | - | -6,301,190 | 14,224,000 | 0.19% |
Feb 14, 2024 | Knighthead Capital Management, LLC | unchanged | - | -703,392 | 1,587,800 | 0.04% |
Feb 14, 2024 | BANK OF AMERICA CORP /DE/ | unchanged | - | -8,502 | 19,194 | -% |
Feb 14, 2024 | GROUP ONE TRADING, L.P. | unchanged | - | -3,217 | 7,264 | -% |
Unveiling ATI Physical Therapy, Inc.'s Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to ATI Physical Therapy, Inc.)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
UNH | 448.5B | 371.6B | 20.04 | 1.21 | ||||
CI | 103.1B | 195.3B | 19.19 | 0.53 | ||||
CVS | 86.2B | 357.8B | 10.32 | 0.24 | ||||
HCA | 84.5B | 65.0B | 16.12 | 1.3 | ||||
CNC | 40.6B | 154.0B | 15.01 | 0.26 | ||||
DVA | 11.7B | 12.1B | 16.99 | 0.97 | ||||
UHS | 11.4B | 14.3B | 15.93 | 0.8 | ||||
MID-CAP | ||||||||
CHE | 9.3B | 2.3B | 34.2 | 4.12 | ||||
ACHC | 6.5B | 2.9B | -301.31 | 2.23 | ||||
AMN | 2.2B | 3.8B | 10.28 | 0.57 | ||||
AMEH | 2.1B | 1.4B | 34.21 | 1.5 | ||||
SMALL-CAP | ||||||||
ADUS | 1.5B | 1.1B | 24.6 | 1.45 | ||||
BKD | 1.3B | 3.0B | -6.94 | 0.44 | ||||
BEAT | 53.7M | - | -3.67 | - | ||||
AMS | 19.0M | 21.3M | 35.63 | 0.89 |
ATI Physical Therapy, Inc. News
Income Statement (Quarterly) | |||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2019Q4 |
Revenue | 2.7% | 182,292,000 | 177,455,000 | 172,337,000 | 166,932,000 | 161,764,000 | 156,792,000 | 163,293,000 | 153,822,000 | 155,763,000 | 159,013,000 | 164,033,000 | 149,062,000 | 165,016,453 | 148,655,000 | 107,754,000 | - |
Operating Expenses | 0.1% | 153,250,000 | 153,134,000 | 148,124,000 | 147,706,000 | 142,244,000 | 144,523,000 | 143,517,000 | 144,135,000 | 137,978,000 | 136,117,000 | 128,581,000 | 131,121,000 | 125,273,000 | 120,160,000 | 96,615,000 | - |
S&GA Expenses | 5.5% | 26,475,000 | 25,085,000 | 36,573,000 | 30,595,000 | 27,629,000 | 25,263,000 | 31,808,000 | 30,024,000 | 29,897,000 | 30,795,000 | 26,391,000 | 24,726,000 | 30,032,000 | 26,026,000 | 24,791,000 | - |
EBITDA Margin | -2.2% | 0.13 | 0.13 | 0.14 | 0.14 | 0.13 | 0.12 | 0.11 | 0.11 | 0.13 | 0.14 | 0.16 | 0.24 | 0.17 | 0.13 | - | - |
Interest Expenses | -2.8% | 13,895,000 | 14,300,000 | 15,135,000 | 9,563,000 | 12,164,000 | 11,631,000 | 13,890,000 | 3,932,000 | 6,603,000 | 6,618,000 | 13,726,000 | 14,990,000 | 15,346,000 | 12,738,000 | 48,195,000 | - |
Income Taxes | 2192.5% | 2,292,500 | 100,000 | 89,000 | 62,000 | -5,005,000 | -7,218,000 | -13,000,000 | -23,300,000 | -5,381,000 | -35,333,000 | -19,700,000 | -10,515,000 | -2,023,000 | 2,300,000 | 3,568,000 | - |
Earnings Before Taxes | - | - | - | - | - | - | - | - | - | - | - | - | -28,333,000 | - | - | - | - |
EBT Margin | -2.9% | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.05 | - | - |
Net Income | 63.0% | -5,623,000 | -15,197,000 | -22,705,000 | -26,270,000 | -102,765,000 | -116,318,000 | -135,546,000 | -137,750,000 | 821,000 | -324,665,000 | -435,357,000 | -19,127,000 | 1,203,000 | 121,000 | 2,741,000 | - |
Net Income Margin | 59.4% | -0.10 | -0.25 | -0.41 | -0.59 | -0.77 | -0.62 | -0.95 | -1.42 | -1.24 | -1.23 | -0.73 | -0.03 | -0.01 | - | - | - |
Free Cashflow | 115.7% | 2,679,000 | -17,077,000 | 4,325,000 | -19,634,000 | -12,484,000 | -30,593,000 | -15,075,000 | -35,503,000 | -16,029,000 | -21,069,000 | -6,847,000 | -38,448,000 | -6,516,717 | - | - | - |
Balance Sheet | |||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2019Q4 |
Assets | 2.5% | 1,003 | 979 | 1,010 | 1,046 | 1,079 | 1,157 | 1,310 | 1,457 | 1,563 | 1,568 | 2,100 | 346 | 2,610 | 347 | 1,316 | 2,286 |
Current Assets | 36.5% | 169 | 124 | 139 | 167 | 194 | 157 | 191 | 198 | 144 | 163 | 186 | 1.00 | 239 | 2.00 | 0.00 | 152 |
Cash Equivalents | 86.5% | 37.00 | 20.00 | 38.00 | 63.00 | 83.00 | 49.00 | 80.00 | 95.00 | 49.00 | 66.00 | 91.00 | 98.00 | 142 | 154 | 142 | 38.00 |
Net PPE | -8.4% | 100 | 110 | 115 | 120 | 124 | 130 | 135 | 137 | 140 | 135 | 134 | 134 | 137 | - | - | 155 |
Goodwill | 0% | 290 | 290 | 290 | 286 | 286 | 338 | 404 | 492 | 609 | 603 | 911 | 1,300 | 1,330 | - | - | 1,330 |
Liabilities | 3.2% | 879 | 851 | 870 | 885 | 890 | 865 | 902 | 919 | 1,051 | 1,066 | 1,265 | 1,487 | 1,709 | 1,545 | - | 1,381 |
Current Liabilities | 31.0% | 156 | 119 | 126 | 111 | 117 | 116 | 132 | 122 | 137 | 125 | 129 | 6.00 | 143 | 2.00 | 0.00 | 78.00 |
Long Term Debt | -16.7% | 79.00 | 95.00 | 97.00 | 534 | - | 480 | 479 | 478 | 544 | 545 | 547 | 990 | 991 | - | - | 989 |
LT Debt, Current | - | - | - | - | - | - | - | - | - | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 | - | - | 8.00 |
LT Debt, Non Current | - | - | - | - | 534 | 532 | 480 | 479 | 478 | 544 | 545 | 547 | 990 | 991 | - | - | 989 |
Shareholder's Equity | -Infinity% | -95.85 | - | - | 20.00 | 44.00 | 152 | 267 | 398 | 512 | 509 | 836 | 881 | 901 | 901 | 901 | 905 |
Retained Earnings | -0.4% | -1,409 | -1,403 | -1,388 | -1,365 | -1,339 | -1,236 | -1,120 | -984 | -847 | -855 | -523 | -5.81 | -68.80 | -8.81 | -0.02 | -63.03 |
Additional Paid-In Capital | -0.1% | 1,308 | 1,309 | 1,310 | 1,380 | 1,379 | 1,377 | 1,375 | 1,373 | 1,352 | 1,351 | 1,349 | 11.00 | 955 | 14.00 | 0.00 | 953 |
Shares Outstanding | 0% | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 3.00 | 3.00 | - | - | - |
Minority Interest | 15.9% | 5.00 | 4.00 | 5.00 | 5.00 | 4.00 | 5.00 | 6.00 | 6.00 | 7.00 | 7.00 | 10.00 | 15.00 | 17.00 | - | - | 16.00 |
Float | - | - | - | 17.00 | - | - | - | 147 | - | - | - | 734 | - | 367 | - | - | - |
Cashflow (Quarterly) | |||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2018Q4 |
Cashflow From Operations | 143.4% | 5,409 | -12,475 | 8,924 | -14,224 | -6,428 | -26,343 | -6,006 | -26,731 | -3,437 | -11,554 | 2,963 | -30,072 | -317 | -450 | 118,740 | 1,872 | - | - |
Share Based Compensation | -3.7% | 2,216 | 2,300 | 2,800 | 1,500 | 1,529 | 1,900 | 2,000 | 1,960 | 890 | 1,248 | 3,112 | 504 | 503 | 473 | 466 | 494 | - | - |
Cashflow From Investing | 39.5% | -2,730 | -4,511 | -5,046 | -5,079 | -6,186 | -4,244 | -8,960 | -8,658 | -11,186 | -9,760 | -10,181 | -8,762 | -3,058 | -345,000 | -4,274 | -6,958 | - | - |
Cashflow From Financing | 1565.7% | 14,393 | -982 | -29,255 | -761 | 47,184 | -524 | -151 | 81,570 | -2,853 | -3,163 | 110 | -5,617 | -2,668 | 346,916 | -21,041 | 15,405 | - | - |
Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | |
---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | |
Net revenue | $ 699,016 | $ 635,671 |
Cost of services: | ||
Salaries and related costs | 382,370 | 357,982 |
Rent, clinic supplies, contract labor and other | 208,593 | 202,568 |
Provision for doubtful accounts | 11,251 | 13,869 |
Total cost of services | 602,214 | 574,419 |
Selling, general and administrative expenses | 118,728 | 114,724 |
Goodwill, intangible and other asset impairment charges | 5,591 | 486,262 |
Operating loss | (27,517) | (539,734) |
Change in fair value of 2L Notes | (24,471) | 0 |
Change in fair value of warrant liability | (95) | (4,243) |
Change in fair value of contingent common shares liability | (2,257) | (42,525) |
Interest expense, net | 61,039 | 45,278 |
Other expense, net | 1,777 | 3,333 |
Loss before taxes | (63,510) | (541,577) |
Income tax expense (benefit) | 2,568 | (48,530) |
Net loss | (66,078) | (493,047) |
Net income (loss) attributable to non-controlling interests | 3,717 | (668) |
Net loss attributable to ATI Physical Therapy, Inc. | (69,795) | (492,379) |
Less: Series A Senior Preferred Stock redemption value adjustments | 38,958 | 0 |
Less: Series A Senior Preferred Stock cumulative dividend | 23,219 | 17,876 |
Net loss available to common stockholders, diluted | (131,972) | (510,255) |
Net loss available to common stockholders, basic | $ (131,972) | $ (510,255) |
Loss per share of Class A common stock: | ||
Basic (in dollars per share) | $ (31.93) | $ (125.59) |
Diluted (in dollars per share) | $ (31.93) | $ (125.59) |
Weighted average shares outstanding: | ||
Basic (in shares) | 4,133 | 4,063 |
Diluted (in shares) | 4,133 | 4,063 |
Net patient revenue | ||
Net revenue | $ 636,095 | $ 575,940 |
Other revenue | ||
Net revenue | $ 62,921 | $ 59,731 |
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 | ||
---|---|---|---|---|
Current assets: | ||||
Cash and cash equivalents | $ 36,802 | $ 83,139 | ||
Accounts receivable (net of allowance for doubtful accounts of $48,055 and $47,620 at December 31, 2023 and December 31, 2022, respectively) | 88,512 | 80,673 | ||
Prepaid expenses | 12,920 | 13,526 | ||
Insurance recovery receivable | 23,981 | 933 | ||
Other current assets | 4,367 | 9,107 | ||
Assets held for sale | 2,056 | 6,755 | ||
Total current assets | 168,638 | 194,133 | ||
Property and equipment, net | 100,422 | 123,690 | ||
Operating lease right-of-use assets | 194,423 | 226,092 | ||
Goodwill, net | 289,650 | 286,458 | ||
Trade name and other intangible assets, net | 245,858 | 246,582 | ||
Other non-current assets | 4,290 | 2,030 | ||
Total assets | 1,003,281 | 1,078,985 | ||
Current liabilities: | ||||
Accounts payable | 14,704 | 12,559 | ||
Accrued expenses and other liabilities | 88,435 | 53,672 | ||
Current portion of operating lease liabilities | 51,530 | 47,676 | ||
Liabilities held for sale | 1,778 | 2,614 | ||
Total current liabilities | 156,447 | 116,521 | ||
Long-term debt, net | [1] | 433,578 | 531,600 | |
2L Notes due to related parties, at fair value | 79,472 | 0 | ||
Warrant liability | 3 | 98 | ||
Contingent common shares liability | 578 | 2,835 | ||
Deferred income tax liabilities | 21,367 | 18,886 | ||
Operating lease liabilities | 185,602 | 218,424 | ||
Other non-current liabilities | 1,696 | 1,834 | ||
Total liabilities | 878,743 | 890,198 | ||
Commitments and contingencies (Note 17) | ||||
Mezzanine equity: | ||||
Series A Senior Preferred Stock, $0.0001 par value; 1.0 million shares authorized; 0.2 million shares issued and outstanding; $1,249.06 stated value per share at December 31, 2023; $1,108.34 stated value per share at December 31, 2022 | 220,393 | 140,340 | ||
Stockholders' equity: | ||||
Class A common stock, $0.0001 par value; 470.0 million shares authorized; 4.2 million shares issued, 4.0 million shares outstanding at December 31, 2023; 4.1 million shares issued, 4.0 million shares outstanding at December 31, 2022 | 0 | 0 | ||
Treasury stock, at cost, 0.007 million shares and 0.002 million shares at December 31, 2023 and December 31, 2022, respectively | (219) | (146) | ||
Additional paid-in capital | 1,308,119 | 1,378,716 | ||
Accumulated other comprehensive income | 406 | 4,899 | ||
Accumulated deficit | (1,409,306) | (1,339,511) | ||
Total ATI Physical Therapy, Inc. equity | (101,000) | 43,958 | ||
Non-controlling interests | 5,145 | 4,489 | ||
Total stockholders' equity | (95,855) | 48,447 | ||
Total liabilities, mezzanine equity and stockholders' equity | $ 1,003,281 | $ 1,078,985 | ||
|
 | Ms. Sharon Vitti |
---|---|
 | atipt.com |
 | Healthcare Plans |
 | 5700 |